Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Talisomycin [USAN:INN]
RN: 65057-90-1
UNII: F6W58M21O7
InChIKey: VUPBDWQPEOWRQP-RIJHKAIISA-N

Note

  • Contains components A & B; glycopeptide related to bleomycin antibiotic from actinomycetes strain 6465-94.

Molecular Formula

  • C68-H110-N22-O27-S2

Molecular Weight

  • 1731.876
 

Classification Codes

  • Antineoplastic
  • Drug / Therapeutic Agent
  • Mutation Data
  • Natural Product
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Talisomycin
  • Talisomycin [USAN:INN]
  • Tallysomycin A

Synonyms

  • Antibiotic BU 2231A
  • Bleomycinamide, N(sup 1)-(4-amino-6-((3-((4-aminobutyl)amino)propyl)amino)-6-oxohexyl)-13-((4-amino-4,6-dideoxy-alpha-L-talopyranosyl)oxy)-19-demethyl-12-hydroxy-
  • BU 2231A
  • BU-2231A
  • N(sup 1)-(4-Amino-5-((3-((4-aminobutyl)amino)propyl)carbamoyl)pentyl)-13-((4-amino-4,6-dideoxy-alpha-L-talopyranosyl)oxy)-19-demethyl-12-hydroxybleomycinamide
  • Talisomycin
  • Talisomycin A
  • Talisomycina
  • Talisomycina [INN-Spanish]
  • Talisomycine
  • Talisomycine [INN-French]
  • Talisomycinum
  • Talisomycinum [INN-Latin]
  • Tallysomycin
  • Tallysomycin A
  • TLM A
  • UNII-F6W58M21O7

Systematic Name

  • Bleomycinamide, N(sup 1)-(4-amino-6-((3-((4-aminobutyl)amino)propyl)amino)-6-oxohexyl)-13-((4-amino-4,6-dideoxy-alpha-L-talopyranosyl)oxy)-19-demethyl-12-hydroxy-

Registry Numbers

CAS Registry Number

  • 65057-90-1

FDA UNII

  • F6W58M21O7

Other Registry Number

  • 64156-59-8

System Generated Number

  • 0065057901

Structure Descriptors

InChI

1S/C68H110N22O27S2/c1-25-42(87-57(89-55(25)74)31(16-38(72)95)81-18-30(71)56(75)105)59(107)88-44(52(32-19-78-24-82-32)114-67-54(48(101)45(98)36(20-91)113-67)115-66-50(103)53(116-68(76)110)46(99)37(21-92)112-66)61(109)83-26(2)35(94)17-40(97)86-43(27(3)93)60(108)90-62(117-65-49(102)47(100)41(73)28(4)111-65)51(104)64-85-34(23-119-64)63-84-33(22-118-63)58(106)80-13-7-9-29(70)15-39(96)79-14-8-12-77-11-6-5-10-69/h19,22-24,26-31,35-37,41,43-54,62,65-67,77,81,91-94,98-104H,5-18,20-21,69-71,73H2,1-4H3,(H2,72,95)(H2,75,105)(H2,76,110)(H,78,82)(H,79,96)(H,80,106)(H,83,109)(H,86,97)(H,88,107)(H,90,108)(H2,74,87,89)/t26-,27-,28+,29?,30+,31+,35+,36+,37-,41-,43+,44+,45-,46-,47-,48+,49-,50+,51?,52+,53+,54+,62?,65+,66-,67+/m1/s1

InChIKey

VUPBDWQPEOWRQP-RIJHKAIISA-N

Smiles

C[C@@H](O)[C@H](NC(=O)C[C@H](O)[C@@H](C)NC(=O)[C@@H](NC(=O)c1nc(nc(N)c1C)[C@H](CC(=O)N)NC[C@H](N)C(=O)N)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2O[C@H]3O[C@H](CO)[C@@H](O)[C@H](OC(=O)N)[C@@H]3O)c4c[nH]cn4)C(=O)NC(O[C@@H]5O[C@@H](C)[C@@H](N)[C@@H](O)[C@H]5O)C(O)c6nc(cs6)c7nc(cs7)C(=O)NCCCC(N)CC(=O)NCCCNCCCCN

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 19mg/kg (19mg/kg)   Journal of Antibiotics. Vol. 31, Pg. 667, 1978.
mouse LD50 intravenous 17mg/kg (17mg/kg)   Journal of Antibiotics. Vol. 31, Pg. 667, 1978.
mouse LD50 subcutaneous 28mg/kg (28mg/kg)   United States Patent Document. Vol. #4051237,
mouse LD50 subcutaneous 28mg/kg (28mg/kg)   United States Patent Document. Vol. #4051237,